Zapata Quantum (ZPTA) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
4 Sep, 2026Executive summary
The annual meeting will be held virtually on October 9, 2026, to address key governance and operational proposals.
Shareholders will vote on director elections, a reverse stock split, auditor ratification, executive compensation, and meeting adjournment.
The record date for voting eligibility is September 9, 2026, with 233,954,484 total voting shares.
Voting matters and shareholder proposals
Election of three directors for staggered terms (one, two, and three years).
Approval of a reverse stock split at a ratio between 1-for-2 and 1-for-50 to meet exchange listing requirements.
Ratification of Weinberg & Company as independent auditor for 2026.
Advisory vote on executive compensation (say-on-pay) and on the frequency of future say-on-pay votes (recommended every three years).
Approval to adjourn the meeting if more time is needed for proxy solicitation.
Board of directors and corporate governance
Board consists of three directors, each nominated for staggered terms; all are current directors.
Board committees include Audit, Compensation, and Nominating & Corporate Governance, each with defined charters and compliance with SEC and Sarbanes-Oxley requirements.
Board leadership is separated between CEO and Chairman roles.
All directors attended over 75% of meetings in 2025.
Latest events from Zapata Quantum
- No revenue, $3.1M net loss YTD, $13.8M raised, cash sufficient for 12+ months.ZPTA
Q2 2026 - Leading quantum software innovator with pioneering IP, major partnerships, and breakthrough applications.ZPTA
Investor presentation - Quantum software breakthroughs and AI partnerships set the stage for rapid growth and industry leadership.ZPTA
Global Technology Virtual Investor Conference - Quantum software firm resumes operations post-restructuring, but faces high risk and dilution.ZPTA
Registration filing - Quantum software firm relaunches post-restructuring, targeting growth amid high risk and dilution.ZPTA
Registration filing - Q1 2026 net loss rose to $1.3M; $15M Series D financing secured in April extends liquidity.ZPTA
Q1 2026 - No 2025 revenue, positive net income from restructuring, but significant going concern risk remains.ZPTA
Q4 2025 - Equity line resale of up to 13M shares exposes company to high dilution and ongoing losses.ZPTA
Registration Filing - Revenue up 40% to $2M, gross margin 36%, but net loss widens; $30M+ pipeline drives outlook.ZPTA
Q2 2024